CDMRP Pancreatic Cancer Research Program Idea Development Award

The mission of the PCARP is to promote rigorous, innovative, high-impact research that leads to new pancreatic cancer diagnostic and therapeutic tools through collaboration.

• Early detection research for pancreatic cancer, including the prevalence in individuals with pre-diabetes and diabetes and/or those in underserved ethnic and minority communities
• Supportive care interventions, patient-reported outcomes, quality of life, and perspectives during treatment and survivorship
• Understanding the relationship between metabolic disruptions in pancreatic cancer and their systemic effects, including diabetes and cachexia
• Understanding precursors, origins, and early progression of pancreatic cancer
• Understanding the events that promote pancreatic cancer metastasis
• Understanding the relationship between oncogenic signaling and the tumor microenvironment that drives drug resistance and therapeutic response
• New drug development targeted toward cancer sensitivity and resistance mechanisms including immune mechanisms of resistance

It is expected that four (4) idea awards and five (5)  early career partnership awards will be granted. 

Funding: $500,000 total (Partnering Option for Early-Career Investigator $650,000)

Duration: 3 years 

Research Authority due date: 30.6.22

Pre application (required) due date: 8.7.22

Full proposal due date: 6.10.22